Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-02

AUTHORS

C. F. Deacon, L. B. Knudsen, K. Madsen, F. C. Wiberg, O. Jacobsen, J. J. Holst

ABSTRACT

Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy. More... »

PAGES

271-278

Journal

TITLE

Diabetologia

ISSUE

3

VOLUME

41

Related Patents

  • Glp-1 Derivatives And Transmicosal Absorption Preparations Thereof
  • Stabilized Pharmaceutical Formulations Of Insulin Aspart
  • Dpp-Iv Resistant Gip Hybrid Polypeptides With Selectable Properties
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Peptide Derivatives Of Exendin-4
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Method For Administering Insulinotropic Peptides
  • Glp-1 Pharmaceutical Compositions
  • Cyclic Peptide Analogues For Non-Invasive Imaging Of Pancreatic Beta-Cells
  • Protracted Glp-1 Compounds
  • Glp-1 Pharmaceutical Compositions
  • Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Glp-1 Derivative And Preparation Thereof Absorbable Via Mucous Membrane
  • Analogues Of Glp-1
  • Modified Glp-1 Peptides With Increased Biological Potency
  • Pharmaceutical Composition Comprising A Glp-1 Agonist, An Insulin And Methionine
  • Use Of Ave0010 For The Treatment Of Diabetes Mellitus Type 2
  • Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Modified Transferrin Fusion Proteins
  • Exendin Variant Peptides
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • N-Terminal Modified Exendin-4
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Glucagon-Like Peptide-1 Analogs
  • Glucagon-Like Peptide-1 Analogs
  • Acylated Glp-1 Compounds
  • Analogues Of Glp-1
  • Glucagon Analogues
  • Insulin Glargine/Lixisenatide Fixed Ratio Formulation
  • Pharmaceutical Composition Comprising A Glp-1-Agonist And Methionine
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • Glp-1, Exendin-4, Peptide Analogs And Uses Thereof
  • Stable Growth Hormone Compounds Resistant To Proteolytic Degradation
  • Cyclic Peptide Analogues For Non-Invasive Imaging Of Pancreatic Beta-Cells
  • Glucagon-Like Peptide-1 Analogs
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Protracted Glp-1 Compounds
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Analogues Of Glp-1
  • Peptide Conjugates Of Glp-1 Receptor Agonists And Gastrin And Their Use
  • Glucagon-Like Peptide-1 Analogs
  • Glp-1 Derivatives And Uses Thereof
  • Conjugated Proteins With Prolonged In Vivo Efficacy
  • Gip And Exendin Hybrid Polypeptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Glp-1 Receptor Agonist Peptide Gastrin Conjugates
  • Analogues Of Glp-1
  • Protracted Exendin-4 Compounds
  • Analogues Of Glp-1
  • Fusion Protein Of An Exendin To Modified Transferrin
  • Protracted Exendin-4 Compounds
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Stable Growth Hormone Compounds Resistant To Proteolytic Degradation
  • Glp-1 Analogs And Uses Thereof
  • Peptide Conjugates Of Glp-1 Receptor Agonists And Gastrin And Their Use
  • Pharmaceutical Combination For Improving Glycemic Control As Add-On Therapy To Basal Insulin
  • Alpha/Beta-Polypeptide Analogs Of Glucagon-Like Peptide-1
  • Fusion Protein Of Exendin-4 To A Transferrin (Tf) Polypeptide
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Pharmaceutical Combination For Use In Glycemic Control In Diabetes Type 2 Patients
  • Glp-1 Derivatives And Transmicosal Absorption Preparations Thereof
  • Glucagon-Like Peptide-1 Analogs
  • Protracted Glp-1 Compounds
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Glp-1, Exendin-4, Peptide Analogs And Uses Thereof
  • Acylated Glp-1 Compounds
  • Method Of Treating A Subject Suffering Stroke Comprising Administering Glucagon-Like Peptide-1 Analogs
  • Acylated Glp-1 Compounds
  • Analogues Of Glp-1
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Combination Of An Insulin And A Glp-1-Agonist
  • Pharmaceutical Composition Comprising A Glp-1 Agonist And Methionine
  • Glp-1 Analogs And Uses Thereof
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • Oral Delivery Of Modified Transferrin Fusion Proteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s001250050903

    DOI

    http://dx.doi.org/10.1007/s001250050903

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1013633156

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9541166


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross Reactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dipeptidyl Peptidase 4", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Stability", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptide 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptide-1 Receptor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Vitro Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin Secretion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreas", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Peptide Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Perfusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Binding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Precursors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Glucagon", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Swine", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Deacon", 
            "givenName": "C. F.", 
            "id": "sg:person.01026605564.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026605564.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Knudsen", 
            "givenName": "L. B.", 
            "id": "sg:person.0671224337.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671224337.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Madsen", 
            "givenName": "K.", 
            "id": "sg:person.01224745375.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224745375.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wiberg", 
            "givenName": "F. C.", 
            "id": "sg:person.0730500720.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730500720.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jacobsen", 
            "givenName": "O.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Holst", 
            "givenName": "J. J.", 
            "id": "sg:person.0632007550.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632007550.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/0026-0495(94)90164-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000673528"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm199205143262003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002597029"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03190278", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006004995", 
              "https://doi.org/10.1007/bf03190278"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03190278", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006004995", 
              "https://doi.org/10.1007/bf03190278"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001250050664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008139775", 
              "https://doi.org/10.1007/s001250050664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001250050664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008139775", 
              "https://doi.org/10.1007/s001250050664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1128/mcb.7.8.2745", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009211257"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(87)91194-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010255523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(87)91194-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010255523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0005-2795(71)90123-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020695941"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0005-2795(71)90123-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020695941"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-0115(84)90066-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024711783"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.42.11.1678", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025259697"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1870337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025891669"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1870337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025891669"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1074/jbc.271.38.23222", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028514054"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1365-2362.1997.1490691.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030514396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1365-2362.1997.1490691.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030514396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/361362a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031441956", 
              "https://doi.org/10.1038/361362a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1515/bchm3.1991.372.1.313", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043420739"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(93)90256-q", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043831406"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(93)90256-q", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043831406"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1432-1033.1993.tb17986.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045335243"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0014-2999(96)00795-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047097301"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(84)90230-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049167410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(84)90230-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049167410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci116186", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051772692"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/jm00059a014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1055933900"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/endo.136.8.7628397", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064280347"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/jcem.80.3.7883856", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064319418"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.38.3.338", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070735825"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.40.11.1488", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070736378"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.42.9.1219", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737139"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.44.9.1126", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737650"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.45.11.1524", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737725"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.15.2.270", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070745632"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.17.9.1039", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070746463"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.19.11.1200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070746952"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.19.8.843", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070747210"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1998-02", 
        "datePublishedReg": "1998-02-01", 
        "description": "Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s001250050903", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1001482", 
            "issn": [
              "0012-186X", 
              "1432-0428"
            ], 
            "name": "Diabetologia", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "41"
          }
        ], 
        "name": "Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity", 
        "pagination": "271-278", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "40f207bec24874f0e8640392b2ede25e0aa3170d5fb680ff40358fdf38da40e4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9541166"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0006777"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s001250050903"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1013633156"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s001250050903", 
          "https://app.dimensions.ai/details/publication/pub.1013633156"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T09:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99803_00000000.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs001250050903"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'


     

    This table displays all metadata directly associated to this object as RDF triples.

    274 TRIPLES      21 PREDICATES      78 URIs      39 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s001250050903 schema:about N02655ce8119e48f88713c1ab6e3a9c97
    2 N0ceec27bb2ba4e21b511fa8830dde805
    3 N258a6f5dfd6c4925be54236707eaee5f
    4 N31138b239ee3426fa24a241307bbc0be
    5 N31738decc31d49959a2706129dbf661d
    6 N33fa96c6c54442d7a42b3ab730b824e1
    7 N407bf2cb887b458f9ca3f545c2ef80e2
    8 N4598b091859447178c7646aad5b84af5
    9 N4b4d75da1b414b8bab26a738189ffac8
    10 N98c64d8728d64d84b1bfac1f71684daf
    11 Na37466abddd5482b815bef1722a495f8
    12 Na39569d479f44af48937ae606ef9c4b5
    13 Na58419d347b24ebb8bab31ac77f2b7b7
    14 Nb9a19a712b924e3584d006d36e45a641
    15 Nbb3acc80e0544e8cb69128211b2697e5
    16 Nbe29f786a7754d5e84f8a475abf31324
    17 Nc20c11ed958e4e80a6ece7068fa1dd06
    18 Ndb44eb9bee1b4714adacc2df31b78098
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 schema:author Nc1c604c984454c26b6cec5d5152a2d74
    22 schema:citation sg:pub.10.1007/bf03190278
    23 sg:pub.10.1007/s001250050664
    24 sg:pub.10.1038/361362a0
    25 https://doi.org/10.1016/0005-2795(71)90123-1
    26 https://doi.org/10.1016/0026-0495(94)90164-3
    27 https://doi.org/10.1016/0167-0115(84)90066-1
    28 https://doi.org/10.1016/0167-4838(84)90230-9
    29 https://doi.org/10.1016/0167-4838(93)90256-q
    30 https://doi.org/10.1016/s0014-2999(96)00795-9
    31 https://doi.org/10.1016/s0140-6736(87)91194-9
    32 https://doi.org/10.1021/jm00059a014
    33 https://doi.org/10.1042/bj1870337
    34 https://doi.org/10.1046/j.1365-2362.1997.1490691.x
    35 https://doi.org/10.1056/nejm199205143262003
    36 https://doi.org/10.1074/jbc.271.38.23222
    37 https://doi.org/10.1111/j.1432-1033.1993.tb17986.x
    38 https://doi.org/10.1128/mcb.7.8.2745
    39 https://doi.org/10.1172/jci116186
    40 https://doi.org/10.1210/endo.136.8.7628397
    41 https://doi.org/10.1210/jcem.80.3.7883856
    42 https://doi.org/10.1515/bchm3.1991.372.1.313
    43 https://doi.org/10.2337/diab.38.3.338
    44 https://doi.org/10.2337/diab.40.11.1488
    45 https://doi.org/10.2337/diab.42.11.1678
    46 https://doi.org/10.2337/diab.42.9.1219
    47 https://doi.org/10.2337/diab.44.9.1126
    48 https://doi.org/10.2337/diab.45.11.1524
    49 https://doi.org/10.2337/diacare.15.2.270
    50 https://doi.org/10.2337/diacare.17.9.1039
    51 https://doi.org/10.2337/diacare.19.11.1200
    52 https://doi.org/10.2337/diacare.19.8.843
    53 schema:datePublished 1998-02
    54 schema:datePublishedReg 1998-02-01
    55 schema:description Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy.
    56 schema:genre research_article
    57 schema:inLanguage en
    58 schema:isAccessibleForFree true
    59 schema:isPartOf N0a9d368e69774a96819107b3d8f7041f
    60 N0ea6b5340f8145efb7018de325c55d6a
    61 sg:journal.1001482
    62 schema:name Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    63 schema:pagination 271-278
    64 schema:productId N3be7bbe3ec3b4041a373b98e5aaf716d
    65 N48f0b408c3c44012822b007d8b1f6dbc
    66 Na474dae49eff41dea40522ca1fa44e79
    67 Na993144830794b03a7f764942b9de0c6
    68 Nd52f88161af6493eb0505127139d11a0
    69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013633156
    70 https://doi.org/10.1007/s001250050903
    71 schema:sdDatePublished 2019-04-11T09:30
    72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    73 schema:sdPublisher N0f21325a572a49a8bb129e19caf7d940
    74 schema:url https://link.springer.com/10.1007%2Fs001250050903
    75 sgo:license sg:explorer/license/
    76 sgo:sdDataset articles
    77 rdf:type schema:ScholarlyArticle
    78 N02655ce8119e48f88713c1ab6e3a9c97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    79 schema:name Cross Reactions
    80 rdf:type schema:DefinedTerm
    81 N0a9d368e69774a96819107b3d8f7041f schema:issueNumber 3
    82 rdf:type schema:PublicationIssue
    83 N0ceec27bb2ba4e21b511fa8830dde805 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    84 schema:name Animals
    85 rdf:type schema:DefinedTerm
    86 N0ea6b5340f8145efb7018de325c55d6a schema:volumeNumber 41
    87 rdf:type schema:PublicationVolume
    88 N0f21325a572a49a8bb129e19caf7d940 schema:name Springer Nature - SN SciGraph project
    89 rdf:type schema:Organization
    90 N10d54fedd2a2435d9c0f332c4edf8f3a rdf:first sg:person.0671224337.40
    91 rdf:rest Ne86e2a1d4669420198a0cf0884d4e9eb
    92 N258a6f5dfd6c4925be54236707eaee5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    93 schema:name Receptors, Glucagon
    94 rdf:type schema:DefinedTerm
    95 N31138b239ee3426fa24a241307bbc0be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    96 schema:name Perfusion
    97 rdf:type schema:DefinedTerm
    98 N31738decc31d49959a2706129dbf661d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Glucagon-Like Peptide 1
    100 rdf:type schema:DefinedTerm
    101 N33fa96c6c54442d7a42b3ab730b824e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name In Vitro Techniques
    103 rdf:type schema:DefinedTerm
    104 N3be7bbe3ec3b4041a373b98e5aaf716d schema:name dimensions_id
    105 schema:value pub.1013633156
    106 rdf:type schema:PropertyValue
    107 N407bf2cb887b458f9ca3f545c2ef80e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Insulin
    109 rdf:type schema:DefinedTerm
    110 N4598b091859447178c7646aad5b84af5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Glucagon
    112 rdf:type schema:DefinedTerm
    113 N48f0b408c3c44012822b007d8b1f6dbc schema:name nlm_unique_id
    114 schema:value 0006777
    115 rdf:type schema:PropertyValue
    116 N4b4d75da1b414b8bab26a738189ffac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    117 schema:name Glucagon-Like Peptide-1 Receptor
    118 rdf:type schema:DefinedTerm
    119 N6fad7d0f0f214d2eb45404f3ddab1c76 rdf:first sg:person.0632007550.38
    120 rdf:rest rdf:nil
    121 N7ead9e0e3da44e99ab7b2f363b227805 rdf:first sg:person.0730500720.11
    122 rdf:rest Na2c5da2d9d1c4c24ba45aac3bd06e3a6
    123 N98c64d8728d64d84b1bfac1f71684daf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Drug Stability
    125 rdf:type schema:DefinedTerm
    126 N9bcaf76a437a44f6889756a299c8abdf schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    127 schema:familyName Jacobsen
    128 schema:givenName O.
    129 rdf:type schema:Person
    130 Na2c5da2d9d1c4c24ba45aac3bd06e3a6 rdf:first N9bcaf76a437a44f6889756a299c8abdf
    131 rdf:rest N6fad7d0f0f214d2eb45404f3ddab1c76
    132 Na37466abddd5482b815bef1722a495f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Pancreas
    134 rdf:type schema:DefinedTerm
    135 Na39569d479f44af48937ae606ef9c4b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Dipeptidyl Peptidase 4
    137 rdf:type schema:DefinedTerm
    138 Na474dae49eff41dea40522ca1fa44e79 schema:name pubmed_id
    139 schema:value 9541166
    140 rdf:type schema:PropertyValue
    141 Na58419d347b24ebb8bab31ac77f2b7b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Peptide Fragments
    143 rdf:type schema:DefinedTerm
    144 Na993144830794b03a7f764942b9de0c6 schema:name doi
    145 schema:value 10.1007/s001250050903
    146 rdf:type schema:PropertyValue
    147 Nb9a19a712b924e3584d006d36e45a641 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    148 schema:name Protein Precursors
    149 rdf:type schema:DefinedTerm
    150 Nbb3acc80e0544e8cb69128211b2697e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Swine
    152 rdf:type schema:DefinedTerm
    153 Nbe29f786a7754d5e84f8a475abf31324 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Protein Binding
    155 rdf:type schema:DefinedTerm
    156 Nc1c604c984454c26b6cec5d5152a2d74 rdf:first sg:person.01026605564.74
    157 rdf:rest N10d54fedd2a2435d9c0f332c4edf8f3a
    158 Nc20c11ed958e4e80a6ece7068fa1dd06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Glucagon-Like Peptides
    160 rdf:type schema:DefinedTerm
    161 Nd52f88161af6493eb0505127139d11a0 schema:name readcube_id
    162 schema:value 40f207bec24874f0e8640392b2ede25e0aa3170d5fb680ff40358fdf38da40e4
    163 rdf:type schema:PropertyValue
    164 Ndb44eb9bee1b4714adacc2df31b78098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Insulin Secretion
    166 rdf:type schema:DefinedTerm
    167 Ne86e2a1d4669420198a0cf0884d4e9eb rdf:first sg:person.01224745375.19
    168 rdf:rest N7ead9e0e3da44e99ab7b2f363b227805
    169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    170 schema:name Medical and Health Sciences
    171 rdf:type schema:DefinedTerm
    172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Clinical Sciences
    174 rdf:type schema:DefinedTerm
    175 sg:journal.1001482 schema:issn 0012-186X
    176 1432-0428
    177 schema:name Diabetologia
    178 rdf:type schema:Periodical
    179 sg:person.01026605564.74 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    180 schema:familyName Deacon
    181 schema:givenName C. F.
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026605564.74
    183 rdf:type schema:Person
    184 sg:person.01224745375.19 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    185 schema:familyName Madsen
    186 schema:givenName K.
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224745375.19
    188 rdf:type schema:Person
    189 sg:person.0632007550.38 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    190 schema:familyName Holst
    191 schema:givenName J. J.
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632007550.38
    193 rdf:type schema:Person
    194 sg:person.0671224337.40 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    195 schema:familyName Knudsen
    196 schema:givenName L. B.
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671224337.40
    198 rdf:type schema:Person
    199 sg:person.0730500720.11 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    200 schema:familyName Wiberg
    201 schema:givenName F. C.
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730500720.11
    203 rdf:type schema:Person
    204 sg:pub.10.1007/bf03190278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006004995
    205 https://doi.org/10.1007/bf03190278
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.1007/s001250050664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008139775
    208 https://doi.org/10.1007/s001250050664
    209 rdf:type schema:CreativeWork
    210 sg:pub.10.1038/361362a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031441956
    211 https://doi.org/10.1038/361362a0
    212 rdf:type schema:CreativeWork
    213 https://doi.org/10.1016/0005-2795(71)90123-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020695941
    214 rdf:type schema:CreativeWork
    215 https://doi.org/10.1016/0026-0495(94)90164-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000673528
    216 rdf:type schema:CreativeWork
    217 https://doi.org/10.1016/0167-0115(84)90066-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024711783
    218 rdf:type schema:CreativeWork
    219 https://doi.org/10.1016/0167-4838(84)90230-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049167410
    220 rdf:type schema:CreativeWork
    221 https://doi.org/10.1016/0167-4838(93)90256-q schema:sameAs https://app.dimensions.ai/details/publication/pub.1043831406
    222 rdf:type schema:CreativeWork
    223 https://doi.org/10.1016/s0014-2999(96)00795-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047097301
    224 rdf:type schema:CreativeWork
    225 https://doi.org/10.1016/s0140-6736(87)91194-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010255523
    226 rdf:type schema:CreativeWork
    227 https://doi.org/10.1021/jm00059a014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055933900
    228 rdf:type schema:CreativeWork
    229 https://doi.org/10.1042/bj1870337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025891669
    230 rdf:type schema:CreativeWork
    231 https://doi.org/10.1046/j.1365-2362.1997.1490691.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030514396
    232 rdf:type schema:CreativeWork
    233 https://doi.org/10.1056/nejm199205143262003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002597029
    234 rdf:type schema:CreativeWork
    235 https://doi.org/10.1074/jbc.271.38.23222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514054
    236 rdf:type schema:CreativeWork
    237 https://doi.org/10.1111/j.1432-1033.1993.tb17986.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045335243
    238 rdf:type schema:CreativeWork
    239 https://doi.org/10.1128/mcb.7.8.2745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009211257
    240 rdf:type schema:CreativeWork
    241 https://doi.org/10.1172/jci116186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051772692
    242 rdf:type schema:CreativeWork
    243 https://doi.org/10.1210/endo.136.8.7628397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064280347
    244 rdf:type schema:CreativeWork
    245 https://doi.org/10.1210/jcem.80.3.7883856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064319418
    246 rdf:type schema:CreativeWork
    247 https://doi.org/10.1515/bchm3.1991.372.1.313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043420739
    248 rdf:type schema:CreativeWork
    249 https://doi.org/10.2337/diab.38.3.338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070735825
    250 rdf:type schema:CreativeWork
    251 https://doi.org/10.2337/diab.40.11.1488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070736378
    252 rdf:type schema:CreativeWork
    253 https://doi.org/10.2337/diab.42.11.1678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025259697
    254 rdf:type schema:CreativeWork
    255 https://doi.org/10.2337/diab.42.9.1219 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737139
    256 rdf:type schema:CreativeWork
    257 https://doi.org/10.2337/diab.44.9.1126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737650
    258 rdf:type schema:CreativeWork
    259 https://doi.org/10.2337/diab.45.11.1524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737725
    260 rdf:type schema:CreativeWork
    261 https://doi.org/10.2337/diacare.15.2.270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070745632
    262 rdf:type schema:CreativeWork
    263 https://doi.org/10.2337/diacare.17.9.1039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746463
    264 rdf:type schema:CreativeWork
    265 https://doi.org/10.2337/diacare.19.11.1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746952
    266 rdf:type schema:CreativeWork
    267 https://doi.org/10.2337/diacare.19.8.843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070747210
    268 rdf:type schema:CreativeWork
    269 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
    270 schema:name Novo Nordisk A/S, Måløv, Denmark, DK
    271 rdf:type schema:Organization
    272 https://www.grid.ac/institutes/grid.5254.6 schema:alternateName University of Copenhagen
    273 schema:name Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK
    274 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...